Abraham Felix, Winifred Pardo, Wilbert Fuerte, Laura Morales, Timothy P Gauthier
{"title":"单中心,回顾性评估需要48小时和24小时药剂师驱动的方案为基础的静脉到静脉阿奇霉素转换。","authors":"Abraham Felix, Winifred Pardo, Wilbert Fuerte, Laura Morales, Timothy P Gauthier","doi":"10.1017/ash.2025.8","DOIUrl":null,"url":null,"abstract":"<p><p>Shortening a pharmacist-driven policy to allow a switch from IV to PO azithromycin after 24 hours instead of 48 hours led to 26% increase in oral azithromycin days of therapy (<i>P</i> < 0.001) and was associated with a shorter length of stay.</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":"5 1","pages":"e65"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869072/pdf/","citationCount":"0","resultStr":"{\"title\":\"Single center, retrospective evaluation of requiring 48 hours versus 24 hours before a pharmacist-driven protocol-based IV to PO conversion of azithromycin.\",\"authors\":\"Abraham Felix, Winifred Pardo, Wilbert Fuerte, Laura Morales, Timothy P Gauthier\",\"doi\":\"10.1017/ash.2025.8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Shortening a pharmacist-driven policy to allow a switch from IV to PO azithromycin after 24 hours instead of 48 hours led to 26% increase in oral azithromycin days of therapy (<i>P</i> < 0.001) and was associated with a shorter length of stay.</p>\",\"PeriodicalId\":72246,\"journal\":{\"name\":\"Antimicrobial stewardship & healthcare epidemiology : ASHE\",\"volume\":\"5 1\",\"pages\":\"e65\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-02-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869072/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antimicrobial stewardship & healthcare epidemiology : ASHE\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1017/ash.2025.8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobial stewardship & healthcare epidemiology : ASHE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/ash.2025.8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
Single center, retrospective evaluation of requiring 48 hours versus 24 hours before a pharmacist-driven protocol-based IV to PO conversion of azithromycin.
Shortening a pharmacist-driven policy to allow a switch from IV to PO azithromycin after 24 hours instead of 48 hours led to 26% increase in oral azithromycin days of therapy (P < 0.001) and was associated with a shorter length of stay.